- Reproduction Rates After Cytotoxic Therapy (vol 27, pg e118, 2009)
[作者:Mispelaere, B; Van de Werf, E; D'Hooghe, T; Dieudonne, AS; Amant, F; Van Mieghem, T; Neven, P; Paridaens, R; Wildiers, H,期刊:Journal of clinical oncology, 页码:5859-5859 , 文章类型: Correction,,卷期:2009年27-34]
-
- Bladder Cancer: Narrowing the Gap Between Evidence and Practice
[作者:Hussain, MHA; Wood, DP; Bajorin, DF; Bochner, BH; Dreicer, R; Lamm, DL; O'Donnell, MA; Siefker-Radtke, AO; Theodorescu, D; Dinney, CP,期刊:Journal of clinical oncology, 页码:5680-5684 , 文章类型: Editorial Material,,卷期:2009年27-34]
-
- Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
[作者:Joensuu, H; Bono, P; Kataja, V; Alanko, T; Kokko, R; Asola, R; Utriainen, T; Turpeenniemi-Hujanen, T; Jyrkkio, S; Moykkynen, K; Helle, L; Ingalsuo, S; Pajunen, M; Huusko, M; Salminen, T; Auvinen, P; Leinonen, H; Leinonen, M; Isola, J; Kellokumpu-Lehtinen, PL,期刊:Journal of clinical oncology, 页码:5685-5692 , 文章类型: Article,,卷期:2009年27-34]
- Purpose Docetaxel has not been compared with vinorelbine as adjuvant treatment of early breast cancer. Efficacy and long-term safety of a short course of adjuvant trastuzumab administered concomitantly with chemotherapy ...
- Clinical Relevance of HER2 Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer
[作者:Curigliano, G; Viale, G; Bagnardi, V; Fumagalli, L; Locatelli, M; Rotmensz, N; Ghisini, R; Colleoni, M; Munzone, E; Veronesi, P; Zurrida, S; Nole, F; Goldhirsch, A,期刊:Journal of clinical oncology, 页码:5693-5699 , 文章类型: Article,,卷期:2009年27-34]
- Purpose To assess the prognostic role of HER2 overexpression/amplification in patients with node-negative, pT1a-b breast cancers. Patients and Methods All patients with HER2-positive breast cancer were identified among a...
- High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2-Positive, Node-Negative Tumors 1 cm or Smaller
[作者:Gonzalez-Angulo, AM; Litton, JK; Broglio, KR; Meric-Bernstam, F; Rakkhit, R; Cardoso, F; Peintinger, F; Hanrahan, EO; Sahin, A; Guray, M; Larsimont, D; Feoli, F; Stranzl, H; Buchholz, TA; Valero, V; Theriault, R; Piccart-Gebhart, M; Ravdin, PM; Berry, DA; Hortobagyi, GN,期刊:Journal of clinical oncology, 页码:5700-5706 , 文章类型: Article,,卷期:2009年27-34]
- Purpose To evaluate the risk of recurrence in women diagnosed with T1a and T1b, node-negative, human epidermal growth factor receptor 2 (HER2)-positive breast cancer. Methods We reviewed 965 T1a, bN0M0 breast cancers dia...
|